Literature DB >> 20086267

Design and implementation of a secure and user-friendly broker platform supporting the end-to-end provisioning of e-homecare services.

Sofie Van Hoecke1, Kristof Steurbaut, Kristof Taveirne, Filip De Turck, Bart Dhoedt.   

Abstract

We designed a broker platform for e-homecare services using web service technology. The broker allows efficient data communication and guarantees quality requirements such as security, availability and cost-efficiency by dynamic selection of services, minimizing user interactions and simplifying authentication through a single user sign-on. A prototype was implemented, with several e-homecare services (alarm, telemonitoring, audio diary and video-chat). It was evaluated by patients with diabetes and multiple sclerosis. The patients found that the start-up time and overhead imposed by the platform was satisfactory. Having all e-homecare services integrated into a single application, which required only one login, resulted in a high quality of experience for the patients.

Entities:  

Mesh:

Year:  2010        PMID: 20086267     DOI: 10.1258/jtt.2009.001011

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  3 in total

Review 1.  Informatic nephrology.

Authors:  Carlos Musso; Jerónimo Aguilera; Carlos Otero; Manuel Vilas; Daniel Luna; Fernán González Bernaldo de Quirós
Journal:  Int Urol Nephrol       Date:  2012-10-11       Impact factor: 2.370

2.  Internet portal use in an academic multiple sclerosis center.

Authors:  A Scott Nielsen; John D Halamka; R Philip Kinkel
Journal:  J Am Med Inform Assoc       Date:  2011-05-12       Impact factor: 4.497

Review 3.  Designing, Implementing, and Evaluating Mobile Health Technologies for Managing Chronic Conditions in Older Adults: A Scoping Review.

Authors:  Nancy Matthew-Maich; Lauren Harris; Jenny Ploeg; Maureen Markle-Reid; Ruta Valaitis; Sarah Ibrahim; Amiram Gafni; Sandra Isaacs
Journal:  JMIR Mhealth Uhealth       Date:  2016-06-09       Impact factor: 4.773

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.